90
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Quantifying morbidity associated with the abuse and misuse of opioid analgesics: A comparison of two approaches

, , , , &
Pages 23-30 | Received 27 Apr 2005, Accepted 05 Oct 2005, Published online: 07 Oct 2008

References

  • Substance Abuse and Mental Health Services Administration. Results from the 2003 national survey on drug use and health: national findings. (Office of Applied Studies, NSDUH Series H-25, DHHS Publication No. SMA 04-3964). Rockville, MD, 2004
  • Substance Abuse and Mental Health Administration. Emergency department trends from the drug abuse warning network, final estimates 1995–2002. (Office of Applied Studies, DAWN Series: D-24, DHHS Publication No. SMA 03-3780). Rockville, MD, 2003
  • Inciardi JA, Chambers CD. Patterns of pentazocine abuse and addiction. New York State J Med 1971; 1727–1733
  • Cicero TJ, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH, Senay EC, Woody GE. A post-marketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Abuse 1999; 57: 7–22
  • Johnson LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975–2003. secondary school students (NIH Publication No. 04-5507), National Institute on Drug Abuse, Bethesda, MD 2004; volume 1
  • Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC, Youniss J, Reid N, Rouse WG, Rembert RS, Borys D. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emergency Med 2004; 22: 335–375
  • Riegelman RK, Hirsch RP. Studying a study and testing a test: how to read the health science literature3rd. Little, Brown Company, New York, NY 1996; 213–218
  • Encyclopedia of epidemiologic methods, MH Gail, J Benichou. John Wiley & Sons, Inc., New York, NY 2000; 433–437
  • Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on problems of drug dependence taskforce on prescription opioid nonmedical use and abuse: position statement. Drug Alcohol Dep 2003; 69: 215–232
  • Novak S, Nemeth WC, Lawson KA. Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med 2004; 5: 59–65
  • Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000; 283: 1710–1714
  • Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manage 2004; 28: 176–188
  • Drug Enforcement Administration—Office of Diversion Control. Automation of reports and consolidated orders system. Retail drug summary reports, 1997–2002—Report 4, 2004, Arlington, VA: U.S. Drug Enforcement Administration,
  • 14. U.S. Census Bureau, Decennial Census, 2000.
  • 15. Vector One: Total Patient Tracker; Verispan, LLC, Yardley, PA, 2004, 2002–2004.
  • 16. IMS Health, Inc., Xponent Database- in retail pharmacies and mail order, 2002–2004.
  • Cicero TJ, Inciardi JA. Diversion and abuse of methadone prescribed for pain management. JAMA 2005; 293–297
  • 18. Bond R, personal communication, September 3, 2005
  • 19. Substance Abuse and Mental Health Administration. U.S. Department of Health and Human Services, Center for Substance Abuse Treatment. Methadone-associated mortality: report of a national assessment, 2004.
  • Manchikanti L, Fellows B, Damron KS, Pampati V, McManus CD. Prevalence of illicit drug use among individuals with chronic pain in the commonwealth of Kentucky: An evaluation of patterns and trends. J Ky Med Assoc 2005; 103: 55–62
  • 21. Substance Abuse Services Commission. OxyContin® abuse: Maine's newest epidemic, 2002. Office of Substance Abuse, Maine Department of Behavioral and Developmental Services, Augusta, Maine.
  • Zhukovsky DS, Gorowshi E, Hausdorff J, Napolitano B, Lesser M. Unmet analgesic needs in cancer patients. J Pain Symptom Mange 1995; 10: 113–119
  • Kutner JS, Kassner CT, Nowels DE. Symptom burden at the end of life: hospice providers' perceptions. J Pain Symptom Mange 2001; 21: 473–480
  • Berger A, Dukes E, Smith MY, Hagiwara M, Seifeldin R, Oster G. Patterns of opioid use among metastatic cancer patients at the end of life. J Pain Symptom Mange 2003; 26: 723–730
  • Teno JM, Weitzen S, Wetle T, Mor V. Persistent pain in nursing home residents (research letter). JAMA 2001; 285: 2081

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.